DaVita To Pay Record $495M To Settle Kidney Drug FCA Suit

By Y. Peter Kang · May 4, 2015, 10:01 PM EDT

DaVita Inc. said Monday it set aside $495 million as part of a tentative deal to resolve a False Claims Act whistleblower suit for allegedly bilking taxpayers for reimbursement of intentionally...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login